Ballicules.com

Ethacrynic acid

EDECRIN

What it isNKCC2-inhibiting loop diuretic; edema when a non-sulfonamide option is required.

Why this oneIts lack of a sulfonamide group is its defining niche among loop diuretics.

What limits itOtotoxicity is greater than with other loops; electrolyte depletion and high cost otherwise mirror the class.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Edema / diuresisadult50 mg QD after a meal50-200 mg daily200 mg BID
Edema / diuresispediatric (excl. infants)25 mg QDindividualized

Titration Adjust in 25-50 mg increments; escalate over successive days

Renal Undefined

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy No adequate studies; animal studies showed no teratogenicity; use only if clearly needed.

Lactation Undefined

NO BOXED WARNINGS

Principal riskThe highest ototoxicity of the loop diuretics

Cost, est. cash$10–$300/month

Generic entry2016

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryC

Defining liabilityVolume depletion and electrolyte disturbances; kidney function and interacting medications modify risk.

Mechanism of action: Ethacrynic acid ballicule

Ethacrynic acid ballicule: receptor binding, kinetics and half-life diagram

Open Ethacrynic acid in the interactive console ↗

Memory aids: mascots and interaction avatars

Ethacrynic acid EDECRIN mascot mnemonic cartoon
“Ether cryin’ acid”
Bananas dispersing → ↓ serum potassium
Ethacrynic acid Box: minimal PK interactions avatar
Box: minimal PK interactions

Open Ethacrynic acid in the interactive console ↗